Playback speed
10 seconds
TAVR for Patient with ESRD, Obesity (BMI 46.99), Immobility and Restrictive Lung Disease
331 views
May 23, 2016
Case and Plan:
A 74 year-old female on hemodialysis and morbid obesity presented with worsening ...
read more ↘ shortness of breath and NYHA class III, associated with increased fatigue. TTE revealed severe aortic stenosis; mean gradient = 42 mmHg, Doppler valve area = 0.81 sq cm, Ao peak CW velocity = 4.30 m/sec, LVEF = 60%. A Cardiac Cath on June 6, 2013 revealed mild pulmonary hypertension, normal coronaries, severe AS and underwent surgical balloon aortic valvuloplasty (BA) with AVA increased from 0.7 to 1.0 sqcm. The STS risk mortality: 14.44%, EuroScore II risk mortality: 4.21% and Logistic Euroscore: 28.13%. Patient was determined to be extreme risk for surgical AVR due to ESRD, obesity (BMI 46.99), immobility and restrictive lung disease. Patient is now planned for CoreValve TAVR (29 mm) via transfemoral percutaneous access under conscious sedation.
↖ read less
A 74 year-old female on hemodialysis and morbid obesity presented with worsening ...
read more ↘ shortness of breath and NYHA class III, associated with increased fatigue. TTE revealed severe aortic stenosis; mean gradient = 42 mmHg, Doppler valve area = 0.81 sq cm, Ao peak CW velocity = 4.30 m/sec, LVEF = 60%. A Cardiac Cath on June 6, 2013 revealed mild pulmonary hypertension, normal coronaries, severe AS and underwent surgical balloon aortic valvuloplasty (BA) with AVA increased from 0.7 to 1.0 sqcm. The STS risk mortality: 14.44%, EuroScore II risk mortality: 4.21% and Logistic Euroscore: 28.13%. Patient was determined to be extreme risk for surgical AVR due to ESRD, obesity (BMI 46.99), immobility and restrictive lung disease. Patient is now planned for CoreValve TAVR (29 mm) via transfemoral percutaneous access under conscious sedation.
↖ read less
Login to view comments.
Click here to Login